90 research outputs found

    Ratchet-Like Solitonic Transport in Quantum Hall Bilayers

    Full text link
    The pseudo-spin model for double layer quantum Hall system with total landau level filling factor Ξ½=1\nu=1 is discussed. Unlike the "traditional" one where interlayer voltage enters as static magnetic field along pseudo- spin hard axis, in our model we consider applied interlayer voltage as a frequency of precessing pseudo-magnetic field lying into the easy plane. It is shown that a Landau-Lifshitz equation for the considered pseudo magnetic system well describes existing experimental data. Besides that, the mentioned model predicts novel directed intra-layer transport phenomenon in the system: unidirectional intra-layer energy transport is realized due to interlayer voltage induced motion of topological kinks. This effect could be observed experimentally detecting counter-propagating intra-layer inhomogeneous charge currents which are proportional to the interlayer voltage and total topological charge of the pseudo-spin system.Comment: 4 pages, 4 figure

    Π€Π°ΠΊΡ‚ΠΎΡ€Ρ‹ риска ΠΈ патофизиология контраст-ΠΈΠ½Π΄ΡƒΡ†ΠΈΡ€ΠΎΠ²Π°Π½Π½ΠΎΠΉ Π½Π΅Ρ„Ρ€ΠΎΠΏΠ°Ρ‚ΠΈΠΈ послС ΠΌΡƒΠ»ΡŒΡ‚ΠΈΡΠΏΠΈΡ€Π°Π»ΡŒΠ½ΠΎΠΉ ΠΊΠΎΠΌΠΏΡŒΡŽΡ‚Π΅Ρ€Π½ΠΎΠΉ Ρ‚ΠΎΠΌΠΎΠ³Ρ€Π°Ρ„ΠΈΠΈ с контрастным усилСниСм

    Get PDF
    Introduction. The number of contrast enhanced MDCTΒ is growing everywhere. The risk adverse events after intravascularΒ injection of contrast media increased also. One ofΒ these adverse events is an acute renal injury (known in theΒ literature as a β€œcontrast-induced nephropathy, CIN”).Β Literature data are often contradictory. We need an objectiveΒ analysis of information on the incidence of CIN andΒ evaluation of risk groups for MDCT-CIN.The aim of the study: the evaluation of factors affectingΒ the development of CIN, understanding of its pathophysiology,Β including patients with diabetes mellitus, atΒ contrast-enhanced MDCT.Material and methods. 62 English-language scientificΒ publications, the full text of which and bibliography is availableΒ for search in PubMed (2013–2016 years), were analyzed.Β Factors of pathophysiology of CIN were divided intoΒ groups and subgroups for critical analysis and understandingΒ the contraindications to the use of contrast-enhancedΒ MDCT in the diagnostic process.Results. Age older than 65 years, low baseline estimatedΒ glomerular filtration rate (eGFR), diabetes, low levelsΒ of serum albumin, hypertension predispose patients to CINΒ more often than the modified baseline serum creatinine.Β Intravenous injection of low osmolar CM is not a risk factorΒ in patients with eGFR β‰₯45 ml /kg /1.73 m2. SCr levelsΒ may vary to levels greater than or less than 25% of baselineΒ even without administration of iodinated CM and may not beΒ a reliable diagnostic test.Conclusion. The introduction into the everyday practiceΒ of screening CIN such test as the eGFR, considering the riskΒ of CIN threshold level lower than 45 mL/ min / 1.73 m2,Β will reduce the risk of misidentification of CIN in a large numberΒ of adult inpatients with a threshold level of serum creatinineΒ (SCr) > 1,5 mg /dl.Π’Π²Π΅Π΄Π΅Π½ΠΈΠ΅. ΠšΠΎΠ»ΠΈΡ‡Π΅ΡΡ‚Π²ΠΎ МБКВ с контрастным усилСниСм растСт повсСмСстно, Π° вмСстС с Π½Π΅ΠΉ растСт риск развития ΠΏΠΎΠ±ΠΎΡ‡Π½Ρ‹Ρ… проявлСний внутрисосудистого ввСдСния рСнтгСноконтрастных диагностичСских срСдств,Β Π² частности острого поврСТдСния ΠΏΠΎΡ‡Π΅ΠΊ (извСстного в Π»ΠΈΡ‚Π΅Ρ€Π°Ρ‚ΡƒΡ€Π΅ ΠΊΠ°ΠΊ β€œΠΊΠΎΠ½Ρ‚Ρ€Π°ΡΡ‚-индуцированная нСфропатия – ΠšΠ˜Πβ€). Π›ΠΈΡ‚Π΅Ρ€Π°Ρ‚ΡƒΡ€Π½Ρ‹Π΅ Π΄Π°Π½Π½Ρ‹Π΅ часто ΠΏΡ€ΠΎΡ‚ΠΈΠ²ΠΎΡ€Π΅Ρ‡ΠΈΠ²Ρ‹. НСобходим ΠΎΠ±ΡŠΠ΅ΠΊΡ‚ΠΈΠ²Π½Ρ‹ΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΈΠ½Ρ„ΠΎΡ€ΠΌΠ°Ρ†ΠΈΠΈΒ ΠΎ частотС КИН ΠΈ ΠΎΡ†Π΅Π½ΠΊΠ΅ Π³Ρ€ΡƒΠΏΠΏ риска Π΅Π΅ развития.ЦСль исслСдования: ΠΈΠ·ΡƒΡ‡Π΅Π½ΠΈΠ΅ Ρ„Π°ΠΊΡ‚ΠΎΡ€ΠΎΠ², Π²Π»ΠΈΡΡŽΡ‰ΠΈΡ… Π½Π° Ρ€Π°Π·Π²ΠΈΡ‚ΠΈΠ΅ КИН, осмыслСниС Π΅Π΅ ΠΏΠ°Ρ‚ΠΎΡ„ΠΈΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈΒ ΠΏΡ€ΠΈ Π²Ρ‹ΠΏΠΎΠ»Π½Π΅Π½ΠΈΠΈ МБКВ с контрастным усилСниСм изобраТСния, Π² Ρ‚ΠΎΠΌ числС Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с сахарным Π΄ΠΈΠ°Π±Π΅Ρ‚ΠΎΠΌ.ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π» ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹. ΠŸΡ€ΠΎΠ°Π½Π°Π»ΠΈΠ·ΠΈΡ€ΠΎΠ²Π°Π½Ρ‹ 62 Π½Π°ΡƒΡ‡Π½Ρ‹Π΅ англоязычныС ΠΏΡƒΠ±Π»ΠΈΠΊΠ°Ρ†ΠΈΠΈ, ΠΏΠΎΠ»Π½Ρ‹ΠΉ тСкст ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Ρ…Β ΠΈ ΠΈΡ… библиография доступны Π² поисковой систСмС PubMed (2013–2016 Π³Π³.). Π€Π°ΠΊΡ‚ΠΎΡ€Ρ‹ ΠΏΠ°Ρ‚ΠΎΡ„ΠΈΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠšΠ˜ΠΒ Ρ€Π°Π·Π΄Π΅Π»Π΅Π½Ρ‹ Π½Π° ΠΏΠΎΠ΄Π³Ρ€ΡƒΠΏΠΏΡ‹ ΠΈ ΠΏΠΎΠ΄Π²Π΅Ρ€Π³Π½ΡƒΡ‚Ρ‹ критичСскому анализу для осмыслСния ΠΏΡ€ΠΎΡ‚ΠΈΠ²ΠΎΠΏΠΎΠΊΠ°Π·Π°Π½ΠΈΠΉ ΠΊ использованию МБКВ с контрастным усилСниСм Π² диагностичСском процСссС.Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. Возраст ΡΡ‚Π°Ρ€ΡˆΠ΅ 65 Π»Π΅Ρ‚, Π½ΠΈΠ·ΠΊΠΈΠΉ Π±Π°Π·ΠΎΠ²Ρ‹ΠΉ ΡƒΡ€ΠΎΠ²Π΅Π½ΡŒ расчСтной скорости ΠΊΠ»ΡƒΠ±ΠΎΡ‡ΠΊΠΎΠ²ΠΎΠΉ Ρ„ΠΈΠ»ΡŒΡ‚Ρ€Π°Ρ†ΠΈΠΈ (Ρ€Π‘ΠšΠ€), сахарный Π΄ΠΈΠ°Π±Π΅Ρ‚, Π½ΠΈΠ·ΠΊΠΈΠΉ ΡƒΡ€ΠΎΠ²Π΅Π½ΡŒ сывороточного Π°Π»ΡŒΠ±ΡƒΠΌΠΈΠ½Π°, гипСртония ΠΏΡ€Π΅Π΄Ρ€Π°ΡΠΏΠΎΠ»Π°Π³Π°ΡŽΡ‚ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² ΠΊ КИН Ρ‡Π°Ρ‰Π΅, Ρ‡Π΅ΠΌ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½Π½Ρ‹ΠΉ исходный ΡƒΡ€ΠΎΠ²Π΅Π½ΡŒΒ ΡΡ‹Π²ΠΎΡ€ΠΎΡ‚ΠΎΡ‡Π½ΠΎΠ³ΠΎ ΠΊΡ€Π΅Π°Ρ‚ΠΈΠ½ΠΈΠ½Π° (SCr). Π’Π½ΡƒΡ‚Ρ€ΠΈΠ²Π΅Π½Π½ΠΎΠ΅ Π²Π²Π΅Π΄Π΅Π½ΠΈΠ΅ низкоосмолярных контрастных вСщСств Π½Π΅ являСтся фактором риска Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠΌ с Ρ€Π‘ΠšΠ€ β‰₯45 ΠΌΠ»/ΠΊΠ³/1,73 ΠΌ2.Β Π£Ρ€ΠΎΠ²Π΅Π½ΡŒ SCr ΠΌΠΎΠΆΠ΅Ρ‚ ΠΊΠΎΠ»Π΅Π±Π°Ρ‚ΡŒΡΡ Π΄ΠΎ ΡƒΡ€ΠΎΠ²Π½Π΅ΠΉ, большС или мСньшС, Ρ‡Π΅ΠΌ 25% ΠΎΡ‚ Π±Π°Π·ΠΎΠ²ΠΎΠ³ΠΎ уровня Π΄Π°ΠΆΠ΅ Π±Π΅Π· ввСдСния йодсодСрТащих контрастных вСщСств, ΠΈ Π½Π΅ ΠΌΠΎΠΆΠ΅Ρ‚ ΡΡ‡ΠΈΡ‚Π°Ρ‚ΡŒΡΡ Π½Π°Π΄Π΅ΠΆΠ½Ρ‹ΠΌ диагностичСским тСстом.Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. Π’Π²Π΅Π΄Π΅Π½ΠΈΠ΅ Π² ΠΏΡ€Π°ΠΊΡ‚ΠΈΠΊΡƒ повсСднСвной работы скрининга, основанного Π½Π° ΠΈΠ·ΡƒΡ‡Π΅Π½ΠΈΠΈ Ρ€Π‘ΠšΠ€Β (считая ΠΏΠΎΡ€ΠΎΠ³ΠΎΠΌ риска развития КИН ΡƒΡ€ΠΎΠ²Π΅Π½ΡŒ Π½ΠΈΠΆΠ΅, Ρ‡Π΅ΠΌΒ 45 ΠΌΠ»/ΠΌΠΈΠ½/1,73 ΠΌ2) ΠΏΡ€ΠΈΠ²Π΅Π΄Π΅Ρ‚ ΠΊ ΡΠΎΠΊΡ€Π°Ρ‰Π΅Π½ΠΈΡŽ Π½Π΅ΠΏΡ€Π°Π²ΠΈΠ»ΡŒΠ½ΠΎΠΉ ΠΈΠ΄Π΅Π½Ρ‚ΠΈΡ„ΠΈΠΊΠ°Ρ†ΠΈΠΈ риска КИН Ρƒ большого числа взрослых стационарных Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… с ΠΏΠΎΡ€ΠΎΠ³ΠΎΠ²Ρ‹ΠΌ ΡƒΡ€ΠΎΠ²Π½Π΅ΠΌΒ SCr >1,5 ΠΌΠ³/Π΄Π»

    АкадСмик РАМН ΠœΠΈΡ…Π°ΠΈΠ» Π˜Π»ΡŒΠΈΡ‡ ΠšΡƒΠ·ΠΈΠ½ ΠΈ Π΅Π³ΠΎ Π΄Π΅ΡΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ Π²ΠΎ Π³Π»Π°Π²Π΅ Π˜Π½ΡΡ‚ΠΈΡ‚ΡƒΡ‚Π° Ρ…ΠΈΡ€ΡƒΡ€Π³ΠΈΠΈ ΠΈΠΌ. А.Π’. Π’ΠΈΡˆΠ½Π΅Π²ΡΠΊΠΎΠ³ΠΎ АМН Π‘Π‘Π‘Π  (ΠΊ 100-Π»Π΅Ρ‚ΠΈΡŽ со дня роТдСния)

    Get PDF
    The article is dedicated to RAMS Academician M. I. Kuzin (1916–2009) and to his work as the head of the A. V. Vishnevsky Institute of Surgery of the AMS of the USSR (1976–1988). It is shown that M. I. Kuzin, becoming the head of the main surgical Research Institute of the country, not only developed many surgery areas, which were initiated by his predecessor – the academician of the AMS of the USSR – A. A. Vishnevsky and some exponents of his school (particularly, these are cardiac, thoracic and abdominal surgery), he extended some of areas (for example, peptic ulcer surgery, vast burns and wounds surgery), but also he laid the basis for new areas (liver surgery, endoscopic surgery, and so on). In general, 12-year-activity of M. I. Kuzin as the head of the A. V. Vishnevsky Institute of Surgery of the AMS of the USSR (and then he delegated his directorship to the academician of the AMS of the USSR V. D. Fedorov) was very profitable for progressive advance of collective, and this helped the Institute to become the β€œCollective of high culture” in 1979 and β€œThe Exemplary Institution of Moscow” in 1981.Π‘Ρ‚Π°Ρ‚ΡŒΡ посвящСна Π°ΠΊΠ°Π΄Π΅ΠΌΠΈΠΊΡƒ РАМН ΠœΠΈΡ…Π°ΠΈΠ»Ρƒ Π˜Π»ΡŒΠΈΡ‡Ρƒ ΠšΡƒΠ·ΠΈΠ½Ρƒ (1916–2009) ΠΈ Π΅Π³ΠΎ Π΄Π΅ΡΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΠΈ Π² качСствС Π΄ΠΈΡ€Π΅ΠΊΡ‚ΠΎΡ€Π° Π˜Π½ΡΡ‚ΠΈΡ‚ΡƒΡ‚Π° Ρ…ΠΈΡ€ΡƒΡ€Π³ΠΈΠΈ ΠΈΠΌ. А. Π’. Π’ΠΈΡˆΠ½Π΅Π²ΡΠΊΠΎΠ³ΠΎ АМН Π‘Π‘Π‘Π  (1976–1988). Встав Π²ΠΎ Π³Π»Π°Π²Π΅ Π²Π΅Π΄ΡƒΡ‰Π΅Π³ΠΎ хирургичСского Π½Π°ΡƒΡ‡Π½ΠΎ-ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Ρ‚Π΅Π»ΡŒΡΠΊΠΎΠ³ΠΎ института страны, М. И. ΠšΡƒΠ·ΠΈΠ½ Π½Π΅ Ρ‚ΠΎΠ»ΡŒΠΊΠΎ Ρ€Π°Π·Π²ΠΈΠ» ΠΌΠ½ΠΎΠ³ΠΈΠ΅ направлСния Ρ…ΠΈΡ€ΡƒΡ€Π³ΠΈΠΈ, Π½Π°Ρ‡Π°Ρ‚Ρ‹Π΅ Π΅Π³ΠΎ ΠΏΡ€Π΅Π΄ΡˆΠ΅ΡΡ‚Π²Π΅Π½Π½ΠΈΠΊΠΎΠΌ, Π°ΠΊΠ°Π΄Π΅ΠΌΠΈΠΊΠΎΠΌ АМН Π‘Π‘Π‘Π  А. А. Π’ΠΈΡˆΠ½Π΅Π²ΡΠΊΠΈΠΌ, ΠΈ прСдставитСлями Π΅Π³ΠΎ ΡˆΠΊΠΎΠ»Ρ‹ (Π² частности, ΡΠ΅Ρ€Π΄Π΅Ρ‡Π½ΡƒΡŽ, Ρ‚ΠΎΡ€Π°ΠΊΠ°Π»ΡŒΠ½ΡƒΡŽ ΠΈ Π°Π±Π΄ΠΎΠΌΠΈΠ½Π°Π»ΡŒΠ½ΡƒΡŽ Ρ…ΠΈΡ€ΡƒΡ€Π³ΠΈΡŽ), ΠΈ ΡƒΠ³Π»ΡƒΠ±ΠΈΠ» Π½Π΅ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Π΅ ΠΈΠ· Π½ΠΈΡ… (Π½Π°ΠΏΡ€ΠΈΠΌΠ΅Ρ€, Ρ…ΠΈΡ€ΡƒΡ€Π³ΠΈΡŽ язвСнной Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΠΆΠ΅Π»ΡƒΠ΄ΠΊΠ° ΠΈ двСнадцатипСрстной кишки, Ρ…ΠΈΡ€ΡƒΡ€Π³ΠΈΡŽ ΠΎΠ±ΡˆΠΈΡ€Π½Ρ‹Ρ… Ρ€Π°Π½ ΠΈ ΠΎΠΆΠΎΠ³ΠΎΠ²), Π½ΠΎ ΠΈ Π·Π°Π»ΠΎΠΆΠΈΠ» основы Π½ΠΎΠ²Ρ‹Ρ… Π½Π°ΠΏΡ€Π°Π²Π»Π΅Π½ΠΈΠΉ (хирургия ΠΏΠ΅Ρ‡Π΅Π½ΠΈ, эндоскопичСская хирургия ΠΈ Π΄Ρ€.). Π’ Ρ†Π΅Π»ΠΎΠΌ 12-лСтняя Π΄Π΅ΡΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ М. И. ΠšΡƒΠ·ΠΈΠ½Π° Π½Π° посту Π΄ΠΈΡ€Π΅ΠΊΡ‚ΠΎΡ€Π° Π˜Π½ΡΡ‚ΠΈΡ‚ΡƒΡ‚Π° Ρ…ΠΈΡ€ΡƒΡ€Π³ΠΈΠΈ ΠΈΠΌ. А. Π’. Π’ΠΈΡˆΠ½Π΅Π²ΡΠΊΠΎΠ³ΠΎ АМН Π‘Π‘Π‘Π , ΠΊΠΎΡ‚ΠΎΡ€Ρ‹ΠΉ Π² 1988 Π³. ΠΎΠ½ ΠΏΠ΅Ρ€Π΅Π΄Π°Π» Π°ΠΊΠ°Π΄Π΅ΠΌΠΈΠΊΡƒ АМН Π‘Π‘Π‘Π  Π’. Π”. Π€Π΅Π΄ΠΎΡ€ΠΎΠ²Ρƒ, ΠΏΠ»ΠΎΠ΄ΠΎΡ‚Π²ΠΎΡ€Π½ΠΎ сказалась Π½Π° ΠΏΠΎΡΡ‚ΡƒΠΏΠ°Ρ‚Π΅Π»ΡŒΠ½ΠΎΠΌ Π΄Π²ΠΈΠΆΠ΅Π½ΠΈΠΈ ΠΊΠΎΠ»Π»Π΅ΠΊΡ‚ΠΈΠ²Π° Π²ΠΏΠ΅Ρ€Π΅Π΄, Ρ‡Ρ‚ΠΎ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΠ»ΠΎ Π˜Π½ΡΡ‚ΠΈΡ‚ΡƒΡ‚Ρƒ Π² 1979 Π³. ΡΡ‚Π°Ρ‚ΡŒ Β«ΠšΠΎΠ»Π»Π΅ΠΊΡ‚ΠΈΠ²ΠΎΠΌ высокой ΠΊΡƒΠ»ΡŒΡ‚ΡƒΡ€Ρ‹Β», Π° Π² 1981 Π³. – Β«ΠžΠ±Ρ€Π°Π·Ρ†ΠΎΠ²Ρ‹ΠΌ ΡƒΡ‡Ρ€Π΅ΠΆΠ΄Π΅Π½ΠΈΠ΅ΠΌ Π³ΠΎΡ€ΠΎΠ΄Π° ΠœΠΎΡΠΊΠ²Ρ‹Β»

    ΠŸΠ΅Ρ€Π²Ρ‹ΠΉ ΠΎΠΏΡ‹Ρ‚ использования Π½Π΅ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΠΎΠ³ΠΎ картирования Π² Ρ€Π΅ΠΆΠΈΠΌΠ΅ Ρ€Π΅Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ Π²Ρ€Π΅ΠΌΠ΅Π½ΠΈ Π² условиях элСктрофизиологичСской Π»Π°Π±ΠΎΡ€Π°Ρ‚ΠΎΡ€ΠΈΠΈ для лСчСния ΠΆΠ΅Π»ΡƒΠ΄ΠΎΡ‡ΠΊΠΎΠ²ΠΎΠΉ Π°Ρ€ΠΈΡ‚ΠΌΠΈΠΈ

    Get PDF
    Β A clinical case of treatment for ventricular arrhythmia from the right ventricular outflow tract using non-invasive real-time electrophysiological mapping and the β€œAstrocard” navigation system (β€œMeditek”, Russia) is presented. This clinical case demonstrates the accuracy of non-invasive real-time mapping for the diagnosis and treatment of ventricular arrhythmias.Β Β ΠŸΡ€Π΅Π΄ΡΡ‚Π°Π²Π»Π΅Π½ клиничСский случай лСчСния ΠΆΠ΅Π»ΡƒΠ΄ΠΎΡ‡ΠΊΠΎΠ²ΠΎΠΉ Π°Ρ€ΠΈΡ‚ΠΌΠΈΠΈ ΠΈΠ· Π²Ρ‹Π²ΠΎΠ΄Π½ΠΎΠ³ΠΎ ΠΎΡ‚Π΄Π΅Π»Π° ΠΏΡ€Π°Π²ΠΎΠ³ΠΎ ΠΆΠ΅Π»ΡƒΠ΄ΠΎΡ‡ΠΊΠ° с использованиСм Π½Π΅ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΠΎΠ³ΠΎ элСктрофизиологичСского картирования Π² Ρ€Π΅ΠΆΠΈΠΌΠ΅ Ρ€Π΅Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ Π²Ρ€Π΅ΠΌΠ΅Π½ΠΈ ΠΈ отСчСствСнной Π½Π°Π²ΠΈΠ³Π°Ρ†ΠΈΠΎΠ½Π½ΠΎΠΉ систСмы «Астрокард» (АО Β«ΠœΠ΅Π΄ΠΈΡ‚Π΅ΠΊΒ», Россия). Π”Π°Π½Π½ΠΎΠ΅ клиничСскоС наблюдСниС дСмонстрируСт Ρ‚ΠΎΡ‡Π½ΠΎΡΡ‚ΡŒ Π½Π΅ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΠΎΠ³ΠΎ картирования Π² Ρ€Π΅ΠΆΠΈΠΌΠ΅ Ρ€Π΅Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ Π²Ρ€Π΅ΠΌΠ΅Π½ΠΈ для диагностики ΠΈ лСчСния ΠΆΠ΅Π»ΡƒΠ΄ΠΎΡ‡ΠΊΠΎΠ²Ρ‹Ρ… Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΠΉ Ρ€ΠΈΡ‚ΠΌΠ° сСрдца.

    Clinical Implementation of Cardiac Resynchronization Therapy-Regional Disparities across Selected ESC Member Countries.

    Get PDF
    BACKGROUND: The present analysis aimed to estimate the penetration of cardiac resynchronization therapy (CRT) on the basis of the prevalence and incidence of eligible patients in selected European countries and in Israel. METHODS AND RESULTS: The following countries were considered: Italy, Slovakia, Greece, Israel, Slovenia, Serbia, the Czech Republic, Poland, Romania, Hungary, Ukraine, and the Russian Federation. CRT penetration was defined as the number of patients treated with CRT (CRT patients) divided by the prevalence of patients eligible for CRT. The number of CRT patients was estimated as the sum of CRT implantations in the last 5 years, the European Heart Rhythm Association (EHRA) White Book being used as the source. The prevalence of CRT indications was derived from the literature by applying three epidemiologic models, a synthesis of which indicates that 10% of heart failure (HF) patients are candidates for CRT. HF prevalence was considered to range from 1% to 2% of the general population, resulting in an estimated range of prevalence of CRT indication between 1000 and 2000 patients per million inhabitants. Similarly, the annual incidence of CRT indication, representing the potential target population once CRT has fully penetrated, was estimated as between 100 and 200 individuals per million. The results showed the best CRT penetration in Italy (47-93%), while in some countries it was less than 5% (Romania, Russian Federation, and Ukraine). CONCLUSION: CRT penetration differs markedly among the countries analyzed. The main barriers are the lack of reimbursement for the procedure and insufficient awareness of guidelines by the referring physicians

    ЀАКВОРЫ РИБКА Π’ΠžΠ—Π’Π ΠΠ’Π ΠŸΠ Π•Π”Π‘Π•Π Π”ΠΠ«Π₯ ВАΠ₯Π˜ΠΠ Π˜Π’ΠœΠ˜Π™ Π£ ΠŸΠΠ¦Π˜Π•ΠΠ’ΠžΠ’ Π‘ ΠΠ•ΠŸΠΠ ΠžΠšΠ‘Π˜Π—ΠœΠΠ›Π¬ΠΠ«ΠœΠ˜ ЀОРМАМИ Π€Π˜Π‘Π Π˜Π›Π›Π―Π¦Π˜Π˜ ΠŸΠ Π•Π”Π‘Π•Π Π”Π˜Π™ ΠŸΠžΠ‘Π›Π• Π’ΠžΠ ΠΠšΠžΠ‘ΠšΠžΠŸΠ˜Π§Π•Π‘ΠšΠžΠ™ ΠΠ‘Π›ΠΠ¦Π˜Π˜ BOX LESION SET

    Get PDF
    Highlights Identification of risk factors impacting the effectiveness of thoracoscopic ablation according to the box session set scheme will allow us to formulate criteria for the selection of patients with non-paroxysmal atrial fibrillation for epicardial ablation of the left atrium.Duration of atrial fibrillation for more than 7.5 years and the volume of the left atrium indexed to the body surface area of more than 47 mL/m2 statistically significantly reduce the effectiveness of thoracoscopic ablation of stable atrial fibrillation by 34.2 and 55.8% during the three-year follow-up period, respectively.The need to assess the function of left atrium using modern two-dimensional speckle-tracking echocardiography technology should be considered to determine the criteria for the successful ablation of non-paroxysmal atrial fibrillation.Β The aim. To study risk factors for atrial tachyarrhythmias recurrence after thoracoscopic ablation (TSA) of non-paroxysmal atrial fibrillation (AF) in the long-term follow-up period.Methods. Β The retrospective study included a series of 100 patients with non-paroxysmal AF undergoing β€œBox lesion set” TSA with one-stage exclusion of the left atrial (LA) appendage. The efficacy of TSA in the long-term follow-up period was evaluated using 24-h HM ECG results. A retrospective analysis of risk factors for atrial tachyarrhythmias recurrence after TSA was performed. The analysis included the main clinical characteristics of patients in the preoperative period, as well as data of transthoracic echocardiography with inclusion of left atrial strain in the reservoir and conduit phases.Results. In the presented study, the main risk factors for atrial tachyarrhythmias recurrence after TSA were: duration of AF more than 7.5 years and LAVI more than 47 mL/m2. However, univariate analysis showed that for every 1-year increase in the duration of AF, the risk of arrhythmia recurrence after TSA increased 1.07-fold [95% CI: 1.01; 1.17, p = 0.0374], and for every 10 mL/m2 increase in LAVI, the risk of atrial tachyarrhythmia recurrence increased 1.95-fold [95% CI: 1.49; 2.56, p<0.001]. According to the data of two-dimensional speckle-tracking echocardiography there was a tendency towards the decrease of the parameters of left atrial strain in the reservoir phase mainly in patients with AF, which requires further more detailed study on a larger cohort of patients.Conclusion. It is necessary to consider not only the assessment of the anatomy of the left atrium, but its function with the use of modern methods of radial imaging at the preoperative stage in order to improve the effectiveness of TSA β€œBox lesion set” for non-paroxysmal AF in the long-term follow-up period.ΠžΡΠ½ΠΎΠ²Π½Ρ‹Π΅ ΠΏΠΎΠ»ΠΎΠΆΠ΅Π½ΠΈΡΠžΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ Ρ„Π°ΠΊΡ‚ΠΎΡ€ΠΎΠ² риска, Π²Π»ΠΈΡΡŽΡ‰ΠΈΡ… Π½Π° ΡΡ„Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ торакоскопичСской Π°Π±Π»Π°Ρ†ΠΈΠΈ ΠΏΠΎ схСмС box lesion set, ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΡ‚ ΡΡ„ΠΎΡ€ΠΌΡƒΠ»ΠΈΡ€ΠΎΠ²Π°Ρ‚ΡŒ ΠΊΡ€ΠΈΡ‚Π΅Ρ€ΠΈΠΈ ΠΎΡ‚Π±ΠΎΡ€Π° ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с Π½Π΅ΠΏΠ°Ρ€ΠΎΠΊΡΠΈΠ·ΠΌΠ°Π»ΡŒΠ½ΠΎΠΉ фибрилляциСй прСдсСрдий для ΡΠΏΠΈΠΊΠ°Ρ€Π΄ΠΈΠ°Π»ΡŒΠ½ΠΎΠΉ Π°Π±Π»Π°Ρ†ΠΈΠΈ Π»Π΅Π²ΠΎΠ³ΠΎ прСдсСрдия.АнамнСз фибрилляции прСдсСрдий Π±ΠΎΠ»Π΅Π΅ 7,5 Π³ΠΎΠ΄Π° ΠΈ объСм Π»Π΅Π²ΠΎΠ³ΠΎ прСдсСрдия, индСксируСмый ΠΊ ΠΏΠ»ΠΎΡ‰Π°Π΄ΠΈ повСрхности Ρ‚Π΅Π»Π°, Π±ΠΎΠ»Π΅Π΅ 47 ΠΌΠ»/ΠΌ2 статистичСски Π·Π½Π°Ρ‡ΠΈΠΌΠΎ ΡΠ½ΠΈΠΆΠ°ΡŽΡ‚ ΡΡ„Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ торакоскопичСской Π°Π±Π»Π°Ρ†ΠΈΠΈ устойчивых Ρ„ΠΎΡ€ΠΌ фибрилляции прСдсСрдий Π½Π° 34,2 ΠΈ 55,8% Π² Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠ΅ Ρ‚Ρ€Π΅Ρ…Π»Π΅Ρ‚Π½Π΅Π³ΠΎ ΠΏΠ΅Ρ€ΠΈΠΎΠ΄Π° наблюдСния, соотвСтствСнно.Π‘Π»Π΅Π΄ΡƒΠ΅Ρ‚ Ρ€Π°ΡΡΠΌΠΎΡ‚Ρ€Π΅Ρ‚ΡŒ Π½Π΅ΠΎΠ±Ρ…ΠΎΠ΄ΠΈΠΌΠΎΡΡ‚ΡŒ ΠΎΡ†Π΅Π½ΠΊΠΈ Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ состояния Π»Π΅Π²ΠΎΠ³ΠΎ прСдсСрдия с использованиСм соврСмСнной Ρ‚Π΅Ρ…Π½ΠΎΠ»ΠΎΠ³ΠΈΠΈ Π΄Π²ΡƒΡ…ΠΌΠ΅Ρ€Π½ΠΎΠΉ speckle-tracking эхокардиографии для поиска ΠΊΡ€ΠΈΡ‚Π΅Ρ€ΠΈΠ΅Π² успСха Π°Π±Π»Π°Ρ†ΠΈΠΈ Π½Π΅ΠΏΠ°Ρ€ΠΎΠΊΡΠΈΠ·ΠΌΠ°Π»ΡŒΠ½ΠΎΠΉ фибрилляции прСдсСрдий. ЦСль. РСтроспСктивный поиск Ρ„Π°ΠΊΡ‚ΠΎΡ€ΠΎΠ² риска Π²ΠΎΠ·Π²Ρ€Π°Ρ‚Π° прСдсСрдных Ρ‚Π°Ρ…ΠΈΠ°Ρ€ΠΈΡ‚ΠΌΠΈΠΉ послС торакоскопичСской Π°Π±Π»Π°Ρ†ΠΈΠΈ Π½Π΅ΠΏΠ°Ρ€ΠΎΠΊΡΠΈΠ·ΠΌΠ°Π»ΡŒΠ½ΠΎΠΉ фибрилляции прСдсСрдий (ЀП) Π² ΠΎΡ‚Π΄Π°Π»Π΅Π½Π½ΠΎΠΌ ΠΏΠ΅Ρ€ΠΈΠΎΠ΄Π΅ наблюдСния.ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π» ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹. Π’ исслСдованиС Π²ΠΊΠ»ΡŽΡ‡ΠΈΠ»ΠΈ 100 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с Π½Π΅ΠΏΠ°Ρ€ΠΎΠΊΡΠΈΠ·ΠΌΠ°Π»ΡŒΠ½ΠΎΠΉ ЀП, ΠΊΠΎΡ‚ΠΎΡ€Ρ‹ΠΌ Π²Ρ‹ΠΏΠΎΠ»Π½ΠΈΠ»ΠΈ Ρ‚ΠΎΡ€Π°ΠΊΠΎΡΠΊΠΎΠΏΠΈΡ‡Π΅ΡΠΊΡƒΡŽ Π°Π±Π»Π°Ρ†ΠΈΡŽ ΠΏΠΎ схСмС box lesion set с ΠΎΠ΄Π½ΠΎΠΌΠΎΠΌΠ΅Π½Ρ‚Π½ΠΎΠΉ Π°ΠΌΠΏΡƒΡ‚Π°Ρ†ΠΈΠ΅ΠΉ ΡƒΡˆΠΊΠ° Π»Π΅Π²ΠΎΠ³ΠΎ прСдсСрдия. ΠžΡ†Π΅Π½ΠΈΠ»ΠΈ ΡΡ„Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ торакоскопичСской Π°Π±Π»Π°Ρ†ΠΈΠΈ ЀП Π² ΠΎΡ‚Π΄Π°Π»Π΅Π½Π½ΠΎΠΌ ΠΏΠ΅Ρ€ΠΈΠΎΠ΄Π΅ наблюдСния ΠΏΠΎ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Π°ΠΌ суточного холтСровского мониторирования элСктрокардиограммы. ΠŸΡ€ΠΎΠ²Π΅Π»ΠΈ рСтроспСктивный Π°Π½Π°Π»ΠΈΠ· Ρ„Π°ΠΊΡ‚ΠΎΡ€ΠΎΠ² риска Π²ΠΎΠ·Π²Ρ€Π°Ρ‚Π° прСдсСрдных Ρ‚Π°Ρ…ΠΈΠ°Ρ€ΠΈΡ‚ΠΌΠΈΠΉ послС торакоскопичСской Π°Π±Π»Π°Ρ†ΠΈΠΈ. Π’ Π°Π½Π°Π»ΠΈΠ· Π²ΠΊΠ»ΡŽΡ‡ΠΈΠ»ΠΈ основныС клиничСскиС характСристики ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² Π² ΠΏΡ€Π΅Π΄ΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΎΠ½Π½ΠΎΠΌ ΠΏΠ΅Ρ€ΠΈΠΎΠ΄Π΅, Π° Ρ‚Π°ΠΊΠΆΠ΅ Π΄Π°Π½Π½Ρ‹Π΅ Ρ‚Ρ€Π°Π½ΡΡ‚ΠΎΡ€Π°ΠΊΠ°Π»ΡŒΠ½ΠΎΠΉ эхокардиографии с показатСлями Π΄Π΅Ρ„ΠΎΡ€ΠΌΠ°Ρ†ΠΈΠΈ Π»Π΅Π²ΠΎΠ³ΠΎ прСдсСрдия Π² Ρ€Π΅Π·Π΅Ρ€Π²ΡƒΠ°Ρ€Π½ΡƒΡŽ ΠΈ ΠΊΠΎΠ½Π΄ΡƒΠΈΡ‚Π½ΡƒΡŽ Ρ„Π°Π·Ρ‹.Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. ΠžΡΠ½ΠΎΠ²Π½Ρ‹Π΅ Ρ„Π°ΠΊΡ‚ΠΎΡ€Ρ‹ риска Π²ΠΎΠ·Π²Ρ€Π°Ρ‚Π° прСдсСрдных Ρ‚Π°Ρ…ΠΈΠ°Ρ€ΠΈΡ‚ΠΌΠΈΠΉ послС торакоскопичСской Π°Π±Π»Π°Ρ†ΠΈΠΈ ЀП – Π°Π½Π°ΠΌΠ½Π΅Π· ЀП Π±ΠΎΠ»Π΅Π΅ 7,5 Π³ΠΎΠ΄Π° ΠΈ объСм Π»Π΅Π²ΠΎΠ³ΠΎ прСдсСрдия, индСксируСмый ΠΊ ΠΏΠ»ΠΎΡ‰Π°Π΄ΠΈ повСрхности Ρ‚Π΅Π»Π°, Π±ΠΎΠ»Π΅Π΅ 47 ΠΌΠ»/ΠΌ2. Богласно ΠΎΠ΄Π½ΠΎΡ„Π°ΠΊΡ‚ΠΎΡ€Π½ΠΎΠΌΡƒ Π°Π½Π°Π»ΠΈΠ·Ρƒ, ΠΏΡ€ΠΈ ΡƒΠ²Π΅Π»ΠΈΡ‡Π΅Π½ΠΈΠΈ Π΄Π»ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΠΈ Π°Π½Π°ΠΌΠ½Π΅Π·Π° ЀП Π½Π° 1 Π³ΠΎΠ΄ риск Ρ€Π΅Ρ†ΠΈΠ΄ΠΈΠ²Π° Π°Ρ€ΠΈΡ‚ΠΌΠΈΠΈ послС торакоскопичСской Π°Π±Π»Π°Ρ†ΠΈΠΈ ΠΏΠΎΠ²Ρ‹ΡˆΠ°Π΅Ρ‚ΡΡ Π² 1,07 Ρ€Π°Π·Π° (95% Π΄ΠΎΠ²Π΅Ρ€ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹ΠΉ ΠΈΠ½Ρ‚Π΅Ρ€Π²Π°Π» 1,01–­1,17, p = 0,0374), Π° ΠΏΡ€ΠΈ ΡƒΠ²Π΅Π»ΠΈΡ‡Π΅Π½ΠΈΠΈ объСма Π»Π΅Π²ΠΎΠ³ΠΎ прСдсСрдия, индСксируСмого ΠΊ ΠΏΠ»ΠΎΡ‰Π°Π΄ΠΈ повСрхности Ρ‚Π΅Π»Π°, Π½Π° 10 ΠΌΠ»/ΠΌ2 риск Π²ΠΎΠ·Π²Ρ€Π°Ρ‚Π° прСдсСрдной Ρ‚Π°Ρ…ΠΈΠ°Ρ€ΠΈΡ‚ΠΌΠΈΠΈ ΠΏΠΎΠ²Ρ‹ΡˆΠ°Π΅Ρ‚ΡΡ Π² 1,95 Ρ€Π°Π·Π° (95% Π΄ΠΎΠ²Π΅Ρ€ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹ΠΉ ΠΈΠ½Ρ‚Π΅Ρ€Π²Π°Π» 1,49–2,56, p < 0,001). Богласно Π΄Π°Π½Π½Ρ‹ΠΌ Π΄Π²ΡƒΡ…ΠΌΠ΅Ρ€Π½ΠΎΠΉ speckle-tracking эхокардиографии, сниТались ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΠΈ Π΄Π΅Ρ„ΠΎΡ€ΠΌΠ°Ρ†ΠΈΠΈ Π»Π΅Π²ΠΎΠ³ΠΎ прСдсСрдия Π² Ρ€Π΅Π·Π΅Ρ€Π²ΡƒΠ°Ρ€Π½ΡƒΡŽ Ρ„Π°Π·Ρƒ прСимущСствСнно Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с ЀП, Ρ‡Ρ‚ΠΎ Ρ‚Ρ€Π΅Π±ΡƒΠ΅Ρ‚ Π΄Π΅Ρ‚Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ изучСния Π½Π° большСй ΠΊΠΎΠ³ΠΎΡ€Ρ‚Π΅ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ².Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. На ΠΏΡ€Π΅Π΄ΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΎΠ½Π½ΠΎΠΌ этапС слСдуСт ΠΎΡ†Π΅Π½ΠΈΠ²Π°Ρ‚ΡŒ Π½Π΅ Ρ‚ΠΎΠ»ΡŒΠΊΠΎ анатомичСскоС состояниС Π»Π΅Π²ΠΎΠ³ΠΎ прСдсСрдия, Π½ΠΎ ΠΈ Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠ΅ с ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ соврСмСнных ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠ² Π»ΡƒΡ‡Π΅Π²ΠΎΠΉ Π²ΠΈΠ·ΡƒΠ°Π»ΠΈΠ·Π°Ρ†ΠΈΠΈ с Ρ†Π΅Π»ΡŒΡŽ ΠΏΠΎΠ²Ρ‹ΡˆΠ΅Π½ΠΈΡ эффСктивности торакоскопичСской Π°Π±Π»Π°Ρ†ΠΈΠΈ ΠΏΠΎ схСмС box lesion set Π½Π΅ΠΏΠ°Ρ€ΠΎΠΊΡΠΈΠ·ΠΌΠ°Π»ΡŒΠ½ΠΎΠΉ ЀП Π² ΠΎΡ‚Π΄Π°Π»Π΅Π½Π½ΠΎΠΌ ΠΏΠ΅Ρ€ΠΈΠΎΠ΄Π΅ наблюдСния

    Π‘ΠΎΠ²Ρ€Π΅ΠΌΠ΅Π½Π½Ρ‹Π΅ взгляды Π½Π° использованиС анатомичСских ΠΈ ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-анатомичСских шкал, основанных Π½Π° Π΄Π°Π½Π½Ρ‹Ρ… исслСдования SYNTAX, ΠΏΡ€ΠΈ Π²Ρ‹Π±ΠΎΡ€Π΅ стратСгии рСваскуляризации ΠΌΠΈΠΎΠΊΠ°Ρ€Π΄Π°

    Get PDF
    Treatment of patients with multivessel coronary artery disease is percutaneous coronary intervention or coronary artery bypass grafting according to current European and American guidelines. Depending on the anatomical complexity of the coronary artery lesion, one of the methods is chosen, with usage of a risk scale based on the SYNTAX study. However, Syntax score is actively discussed as not an optimal risk scale, because of unmatched with modern clinical possibilities This article presents current, different opinions on anatomical and clino-anatomical risk scores, which allows to choose the optimal method of revascularization for patients with three-vessel disease and/or left main coronary artery lesions.Π›Π΅Ρ‡Π΅Π½ΠΈΠ΅ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с трСхсосудистым ΠΏΠΎΡ€Π°ΠΆΠ΅Π½ΠΈΠ΅ΠΌ ΠΊΠΎΡ€ΠΎΠ½Π°Ρ€Π½Ρ‹Ρ… Π°Ρ€Ρ‚Π΅Ρ€ΠΈΠΉ, согласно СвропСйским ΠΈ амСриканским рСкомСндациям, Π²ΠΊΠ»ΡŽΡ‡Π°Π΅Ρ‚ чрСскоТноС ΠΊΠΎΡ€ΠΎΠ½Π°Ρ€Π½ΠΎΠ΅ Π²ΠΌΠ΅ΡˆΠ°Ρ‚Π΅Π»ΡŒΡΡ‚Π²ΠΎ ΠΈΠ»ΠΈ ΠΊΠΎΡ€ΠΎΠ½Π°Ρ€Π½ΠΎΠ΅ ΡˆΡƒΠ½Ρ‚ΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠ΅. Π’ зависимости ΠΎΡ‚ анатомичСской слоТности пораТСния ΠΊΠΎΡ€ΠΎΠ½Π°Ρ€Π½Ρ‹Ρ… Π°Ρ€Ρ‚Π΅Ρ€ΠΈΠΉ с использованиСм ΡˆΠΊΠ°Π»Ρ‹ SYNTAX score Π²Ρ‹Π±ΠΈΡ€Π°ΡŽΡ‚ ΠΎΠ΄Π½Ρƒ ΠΈΠ· стратСгий лСчСния. Однако Π² послСдниС Π³ΠΎΠ΄Ρ‹ Π² Π½Π°ΡƒΡ‡Π½ΠΎΠΉ Π»ΠΈΡ‚Π΅Ρ€Π°Ρ‚ΡƒΡ€Π΅ Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎ ΠΎΠ±ΡΡƒΠΆΠ΄Π°ΡŽΡ‚ нСдостатки ΡƒΠΊΠ°Π·Π°Π½Π½ΠΎΠΉ ΡˆΠΊΠ°Π»Ρ‹, которая Π½Π΅ ΠΏΠΎΠ»Π½ΠΎΡΡ‚ΡŒΡŽ соотвСтствуСт возмоТностям соврСмСнной клиничСской ΠΏΡ€Π°ΠΊΡ‚ΠΈΠΊΠΈ. Π’ ΠΎΠ±Π·ΠΎΡ€Π΅ освСщСны соврСмСнныС взгляды Π½Π° анатомичСскиС ΠΈ ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-анатомичСскиС ΡˆΠΊΠ°Π»Ρ‹, ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Π΅ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΡŽΡ‚ Π²Ρ‹Π±Ρ€Π°Ρ‚ΡŒ ΠΎΠΏΡ‚ΠΈΠΌΠ°Π»ΡŒΠ½Ρ‹ΠΉ ΠΌΠ΅Ρ‚ΠΎΠ΄ прямой рСваскуляризации ΠΌΠΈΠΎΠΊΠ°Ρ€Π΄Π° Ρƒ Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… с трСхсосудистым ΠΏΠΎΡ€Π°ΠΆΠ΅Π½ΠΈΠ΅ΠΌ ΠΈ/ΠΈΠ»ΠΈ ΠΏΠΎΡ€Π°ΠΆΠ΅Π½ΠΈΠ΅ΠΌ ствола Π»Π΅Π²ΠΎΠΉ ΠΊΠΎΡ€ΠΎΠ½Π°Ρ€Π½ΠΎΠΉ Π°Ρ€Ρ‚Π΅Ρ€ΠΈΠΈ

    ВлияниС индСксируСмого объСма Π»Π΅Π²ΠΎΠ³ΠΎ прСдсСрдия Π½Π° ΡΡ„Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ торакоскопичСского лСчСния фибрилляции прСдсСрдий

    Get PDF
    Research objective: establish the impact of Left Atrium Volume Index (LAVI) on on effectiveness of Thoracoscopic Ablation (TSA) in the Treatment of Atrial Fibrillation (AF) and define the risk factors for manifestation of supraventricular arrhythmias in the long-term follow-up resultsMethods. Prospective cohort study of 121 patients with AF (from 2018 to 2021) who performed TSA. The patients were divided into two groups: patients with increased LAVI (group I), patients with normal LAVI less than 34 ml/m2 (group II).Results. According to echocardiography, the mean LAVI was 45.48 Β± 9.3 ml/m2 and 28.59 Β± 4.13 ml/m2 in groups I and II, respectively (p = 0.012). The mean value of left ventricular ejection fraction (LVEF) according to Teicholz in group I was 61.62 Β± 7.041%, in group II 63.57 Β± 6.16% (p = 0.8). Spearman's сorrelation analysis showed the relationship between LAVI and LVEF before surgery and in the long-term follow-up period, that is agreed with world literature data about contribution left atrial (LA) to left ventricular (LV) function. According to our study, only LAVI < 34 ml/m2 is a risk factor for arrhythmia after TSA. Effectiveness TSA in I group was 77.8%, that is lower than the II group – 88.9%. 3 months after TSA, 20 (17%) patients were required catheter ablations (CA), mainly in I group.Conclusions. Research results showed that an increase in LAVI significantly reduces the effectiveness of TSA in the long-term period by 11.1% compared with LAVI < 34 ml/m2. That are conform with other data of previously submitted works.ЦСль исслСдования: ΡƒΡΡ‚Π°Π½ΠΎΠ²ΠΈΡ‚ΡŒ влияниС индСксируСмого объСма Π»Π΅Π²ΠΎΠ³ΠΎ прСдсСрдия (LAVI) Π½Π° ΡΡ„Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ торакоскопичСской Π°Π±Π»Π°Ρ†ΠΈΠΈ фибрилляции прСдсСрдий (ЀП) (ВА ЀП) ΠΈ ΠΎΠΏΡ€Π΅Π΄Π΅Π»ΠΈΡ‚ΡŒ Ρ„Π°ΠΊΡ‚ΠΎΡ€Ρ‹ риска развития Π½Π°Π΄ΠΆΠ΅Π»ΡƒΠ΄ΠΎΡ‡ΠΊΠΎΠ²Ρ‹Ρ… Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΠΉ Ρ€ΠΈΡ‚ΠΌΠ° Π² ΠΎΡ‚Π΄Π°Π»Π΅Π½Π½ΠΎΠΌ ΠΏΠ΅Ρ€ΠΈΠΎΠ΄Π΅ наблюдСния.ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π» ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹. ΠŸΡ€ΠΎΠ²Π΅Π΄Π΅Π½ΠΎ проспСктивноС ΠΊΠΎΠ³ΠΎΡ€Ρ‚Π½ΠΎΠ΅ исслСдованиС 121 больного с ЀП (с 2018 ΠΏΠΎ 2021 Π³.), ΠΊΠΎΡ‚ΠΎΡ€Ρ‹ΠΌ Π±Ρ‹Π»Π° Π²Ρ‹ΠΏΠΎΠ»Π½Π΅Π½Π° ВА ЀП. ΠŸΠ°Ρ†ΠΈΠ΅Π½Ρ‚Ρ‹ Π±Ρ‹Π»ΠΈ Ρ€Π°Π·Π΄Π΅Π»Π΅Π½Ρ‹ Π½Π° Π΄Π²Π΅ Π³Ρ€ΡƒΠΏΠΏΡ‹: Π² I Π³Ρ€ΡƒΠΏΠΏΡƒ Π±Ρ‹Π»ΠΈ Π²ΠΊΠ»ΡŽΡ‡Π΅Π½Ρ‹ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Ρ‹ с ΡƒΠ²Π΅Π»ΠΈΡ‡Π΅Π½Π½Ρ‹ΠΌ LAVI, Π²ΠΎ II Π³Ρ€ΡƒΠΏΠΏΡƒ – ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Ρ‹ с Π½ΠΎΡ€ΠΌΠ°Π»ΡŒΠ½Ρ‹ΠΌ LAVI ΠΌΠ΅Π½Π΅Π΅ 34 ΠΌΠ»/ΠΌ2.Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹ исслСдования. По Π΄Π°Π½Π½Ρ‹ΠΌ эхокардиографии срСдний ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΡŒ LAVI составил 45,48 Β± 9,3 ΠΌΠ»/ΠΌ2 ΠΈ 28,59 Β± 4,13 ΠΌΠ»/ΠΌ2 Π² I ΠΈ II Π³Ρ€ΡƒΠΏΠΏΠ°Ρ… соотвСтствСнно (p = 0,012). Π‘Ρ€Π΅Π΄Π½Π΅Π΅ Π·Π½Π°Ρ‡Π΅Π½ΠΈΠ΅ Π€Π’ Π›Π– ΠΏΠΎ Π’Π΅ΠΉΡ…ΠΎΠ»ΡŒΡ†Ρƒ Π² I Π³Ρ€ΡƒΠΏΠΏΠ΅ Π±Ρ‹Π»ΠΎ 61,62 Β± 7,041%, Π²ΠΎ II Π³Ρ€ΡƒΠΏΠΏΠ΅ 63,57 Β± 6,16% (p = 0,8). ΠšΠΎΡ€Ρ€Π΅Π»ΡΡ†ΠΈΠΎΠ½Π½Ρ‹ΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΏΠΎ Π‘ΠΏΠΈΡ€ΠΌΠ΅Π½Ρƒ ΠΏΠΎΠΊΠ°Π·Π°Π» взаимосвязь ΠΌΠ΅ΠΆΠ΄Ρƒ LAVI ΠΈ Π€Π’ Π›Π– ΠΊΠ°ΠΊ Π΄ΠΎ ΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΈ, Ρ‚Π°ΠΊ ΠΈ Π² ΠΎΡ‚Π΄Π°Π»Π΅Π½Π½ΠΎΠΌ ΠΏΠ΅Ρ€ΠΈΠΎΠ΄Π΅ наблюдСния, Ρ‡Ρ‚ΠΎ согласуСтся с Π΄Π°Π½Π½Ρ‹ΠΌΠΈ ΠΌΠΈΡ€ΠΎΠ²ΠΎΠΉ Π»ΠΈΡ‚Π΅Ρ€Π°Ρ‚ΡƒΡ€Ρ‹ ΠΎ Π²ΠΊΠ»Π°Π΄Π΅ Π›ΠŸ Π² Ρ€Π°Π±ΠΎΡ‚Ρƒ Π›Π–. Богласно Π½Π°ΡˆΠ΅ΠΌΡƒ исслСдованию, Ρ‚ΠΎΠ»ΡŒΠΊΠΎ LAVI >34 ΠΌΠ»/ΠΌ2 являСтся Ρ„Π°ΠΊΡ‚ΠΎΡ€ΠΎΠΌ риска развития Π°Ρ€ΠΈΡ‚ΠΌΠΈΠΈ послС ВА ЀП. Π’ Π³Ρ€ΡƒΠΏΠΏΠ΅ I ΡΡ„Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ ВА ЀП составила 77,8%, Ρ‡Ρ‚ΠΎ сущСствСнно Π½ΠΈΠΆΠ΅ ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»Π΅ΠΉ восстановлСния синусового Ρ€ΠΈΡ‚ΠΌΠ° ΠΏΠΎ ΡΡ€Π°Π²Π½Π΅Π½ΠΈΡŽ со II Π³Ρ€ΡƒΠΏΠΏΠΎΠΉ – 88,9%. Π§Π΅Ρ€Π΅Π· 3 мСс послС ΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΈ ΠΏΠΎΡ‚Ρ€Π΅Π±ΠΎΠ²Π°Π»ΠΎΡΡŒ Π²Ρ‹ΠΏΠΎΠ»Π½Π΅Π½ΠΈΠ΅ 20 (17%) Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹Ρ… ΠΊΠ°Ρ‚Π΅Ρ‚Π΅Ρ€Π½Ρ‹Ρ… Π°Π±Π»Π°Ρ†ΠΈΠΉ, прСимущСствСнно Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² I Π³Ρ€ΡƒΠΏΠΏΡ‹.Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. Π”Π°Π½Π½Ρ‹Π΅ нашСго исслСдования ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΈ, Ρ‡Ρ‚ΠΎ ΡƒΠ²Π΅Π»ΠΈΡ‡Π΅Π½ΠΈΠ΅ LAVI достовСрно сниТаСт ΡΡ„Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ ВА ЀП Π² ΠΎΡ‚Π΄Π°Π»Π΅Π½Π½ΠΎΠΌ ΠΏΠ΅Ρ€ΠΈΠΎΠ΄Π΅ Π½Π° 11,1% ΠΏΠΎ ΡΡ€Π°Π²Π½Π΅Π½ΠΈΡŽ со II Π³Ρ€ΡƒΠΏΠΏΠΎΠΉ ΠΏΡ€ΠΈ LAVI < 34 ΠΌΠ»/ΠΌ2. ΠŸΠΎΠ»ΡƒΡ‡Π΅Π½Π½Ρ‹Π΅ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹ ΡΠΎΠ³Π»Π°ΡΡƒΡŽΡ‚ΡΡ с Π΄Π°Π½Π½Ρ‹ΠΌΠΈ Ρ€Π°Π½Π΅Π΅ прСдставлСнных Ρ€Π°Π±ΠΎΡ‚
    • …
    corecore